Previous close | 36.20 |
Open | 36.20 |
Bid | 19.40 |
Ask | 22.00 |
Strike | 340.00 |
Expiry date | 2025-06-20 |
Day's range | 36.20 - 36.20 |
Contract range | N/A |
Volume | |
Open interest | 403 |
In a lawsuit filed in federal court in Missouri, Express Scripts by Evernorth, a subsidiary of The Cigna Group (NYSE: CI), demanded that the Federal Trade Commission ("FTC" or the "Commission") retract its July 2024 report, which is filled with false and misleading claims about the pharmacy benefit management (PBM) industry and fails to serve the interests of American consumers.
CI's new launch, a new E-Treatment option, is expected to improve patient satisfaction and operational efficiency.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.